Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Walker: bNabs after Infection and Immunization |
| Strategy: | Prophylactic neutralizing Ab |
| Study Type: | Antibody Screening |
| Species: | Non-Organism Study |
| Stage: | Assays Completed |
| Study Start Date: | 2012-12-21 |
| Study Made Public: | 2013-10-16 |
Title
ATRECA/Ragon Collaboration: High throughput mAb cloning, a proof of concept pilot
Description
CAVD 402 is a monoclonal antibody screening study evaluating evolution from non-neutralizing to broadly neutralizing antibody responses in chronically infected individuals.
Sign in to see full information about this study and to download study data.
Products
No Products used in studyIntegrated data
NAb MAb
Non-integrated data
No non-integrated data is available for this study.